Scrip is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Elbion AG (inflammation and CNS therapeutics) has completed its first venture round, bringing in €35mm ($44mm) for the company. 3i, Burrill & Co., and DVC Deutsche Venture Capital co-led the financing and were joined by AGF Private Equity, Quintiles PharmaBio Development, BayTech Venture Capital, Marubeni Corp., TVM Techno Venture Management, Temasek Holdings, and Mitsubishi Corp.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?